OTCMKTS:ZYXI - Zynex Inc. common stock Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $3.01 +0.01 (+0.33 %) (As of 07/15/2018 02:57 PM ET)Previous Close$3.01Today's Range$2.95 - $3.0152-Week Range$0.65 - $5.50Volume11,626 shsAverage Volume21,412 shsMarket Capitalization$100.03 millionP/E Ratio10.75Dividend YieldN/ABeta0.92 Company ProfileAnalyst RatingsEarnings HistoryHeadlinesSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Receive ZYXI News and Ratings via Email Sign-up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical SymbolOTCMKTS:ZYXI CUSIPN/A Webwww.zynexmed.com Phone303-703-4906 Debt Debt-to-Equity RatioN/A Current Ratio2.23 Quick Ratio2.04 Price-To-Earnings Trailing P/E Ratio10.75 Forward P/E Ratio10.75 P/E GrowthN/A Sales & Book Value Annual Sales$23.43 million Price / Sales4.27 Cash Flow$0.2483 per share Price / Cash12.12 Book Value$0.15 per share Price / Book20.07 Profitability EPS (Most Recent Fiscal Year)$0.22 Net Income$7.36 million Net Margins33.24% Return on Equity356.96% Return on Assets128.90% Miscellaneous Employees109 Outstanding Shares33,230,000Market Cap$100.03 Zynex Inc. common stock (OTCMKTS:ZYXI) Frequently Asked Questions What is Zynex Inc. common stock's stock symbol? Zynex Inc. common stock trades on the OTCMKTS under the ticker symbol "ZYXI." How were Zynex Inc. common stock's earnings last quarter? Zynex Inc. common stock (OTCMKTS:ZYXI) announced its earnings results on Tuesday, May, 8th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. The company earned $6.88 million during the quarter, compared to analysts' expectations of $6.73 million. Zynex Inc. common stock had a net margin of 33.24% and a return on equity of 356.96%. View Zynex Inc. common stock's Earnings History. What is the consensus analysts' recommendation for Zynex Inc. common stock? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zynex Inc. common stock in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." Who are some of Zynex Inc. common stock's key competitors? Some companies that are related to Zynex Inc. common stock include BioLife Solutions (BLFS), Vision Sciences (CGNT), Rockwell Medical (RMTI), Fonar (FONR), Helius Medical Technologies (HSDT), Second Sight Medical Products (EYES), Semler Scientific (SMLR), Edap Tms (EDAP), Viveve Medical (VIVE), BioSig Technologies (BSGM), IRIDEX (IRIX), Soleno Therapeutics (SLNO), Stereotaxis (STXS), Digirad (DRAD) and Nexeon Medsystems (NXNND). Who are Zynex Inc. common stock's key executives? Zynex Inc. common stock's management team includes the folowing people: Mr. Thomas Sandgaard, Founder, Pres, CEO & Chairman (Age 59)Mr. Daniel J. Moorhead, Chief Financial Officer (Age 46)Mr. David B. Mogill, VP of OperationsMr. Robert Bird, VP of MarketingMr. Steve Siefring, Director of Bus. Devel. Has Zynex Inc. common stock been receiving favorable news coverage? Media headlines about ZYXI stock have trended somewhat positive recently, according to Accern. The research firm identifies positive and negative media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Zynex Inc. common stock earned a news impact score of 0.13 on Accern's scale. They also gave news coverage about the company an impact score of 46.76 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term. How do I buy shares of Zynex Inc. common stock? Shares of ZYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Zynex Inc. common stock's stock price today? One share of ZYXI stock can currently be purchased for approximately $3.01. How big of a company is Zynex Inc. common stock? Zynex Inc. common stock has a market capitalization of $100.03 million and generates $23.43 million in revenue each year. The company earns $7.36 million in net income (profit) each year or $0.22 on an earnings per share basis. Zynex Inc. common stock employs 109 workers across the globe. How can I contact Zynex Inc. common stock? Zynex Inc. common stock's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The company can be reached via phone at 303-703-4906 or via email at [email protected] MarketBeat Community Rating for Zynex Inc. common stock (OTCMKTS ZYXI)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 51 (Vote Outperform)Underperform Votes: 45 (Vote Underperform)Total Votes: 96MarketBeat's community ratings are surveys of what our community members think about Zynex Inc. common stock and other stocks. Vote "Outperform" if you believe ZYXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZYXI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/15/2018 by MarketBeat.com StaffFeatured Article: What are Closed-End Mutual Funds?